(Q34061082)

30 July 2017

1 reference

title

Antidepressants: past, present and future (English)

1 reference

30 July 2017

2

Nalepa I

1 reference

30 July 2017

1

Vetulani J

1 reference

PubMed ID

11033340

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

European Journal of Pharmacology

30 July 2017

1 reference

30 July 2017

405

1 reference

30 July 2017

1-3

1 reference

30 July 2017

351-363

1 reference

Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Modification of effects of chronic electroconvulsive shock by voltage-dependent Ca2+ channel blockade with nifedipine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Aged rats are still responsive to the antidepressant and memory-improving effects of oxytocin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Oxytocin acts as an antidepressant in two animal models of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Dynamics of ECT normalization of low G protein function and immunoreactivity in mononuclear leukocytes of patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Ziskind-Somerfeld research Award. The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

The Effects of Seasons and Light Therapy on G Protein Levels in Mononuclear Leukocytes of Patients With Seasonal Affective Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Substance P antagonists: the next breakthrough in treating depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Development of β-adrenergic receptor subsensitivity by antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

The noradrenergic cyclic AMP generating system in the limbic forebrain: Pharmacological characterization in vitro and possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Down-regulation of beta-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Norepinephrine in depressive reactions. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Pharmacology of a new phthaline (Lu 10-171), with specific 5-HT uptake inhibiting properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Cyclic AMP-generating systems: regional differences in activation by adrenergic receptors in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Neuropeptides: animal behaviour and human psychopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Novel therapeutic approaches beyond the serotonin receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Modulation of receptor-mediated cyclic AMP production in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

A molecular and cellular theory of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

The 'serotonin/norepinephrine link' beyond the beta adrenoceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

The effect of transcranial magnetic stimulation of rat brain on behavioral models of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Effect of chronic antidepressant treatment on transcription factor binding activity in rat hippocampus and frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Effect of an uptake inhibitor on serotonin metabolism in rat brain: Studies with 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine (Lilly 110140)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

'Crosstalk': a pivotal role for protein kinase C in modulating relationships between signal transduction pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Role of Serotonergic Input in the Regulation of the β-Adrenergic Receptor-Coupled Adenylate Cyclase System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Role of the dopaminergic system in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Phorbol esters enhance neurotransmitter-stimulated cyclic AMP production in rat brain slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Phorbol esters promote alpha 1-adrenergic receptor phosphorylation and receptor uncoupling from inositol phospholipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Signal-transducing G proteins and antidepressant drugs: evidence for modulation of alpha subunit gene expression in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Neurotrophic factors: from molecule to man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Desipramine given repeatedly enhances behavioural effects of dopamine and d-amphetamine injected into the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Beta-adrenoceptor-linked protein kinase A (PKA) activity in human fibroblasts from normal subjects and from patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

cAMP-dependent phosphorylation system after short and long-term administration of moclobemide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Beta down-regulation induced by repeated vasopressin treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Involvement of protein kinase C in the mechanism of in vitro effects of imipramine on generation of second messengers by noradrenaline in cerebral cortical slices of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Different mechanisms of beta-adrenoceptor down-regulation by chronic imipramine and electroconvulsive treatment: possible role for protein kinase C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Enhancement of the responsiveness of cortical adrenergic receptors by chronic administration of the 5-hydroxytryptamine uptake inhibitor citalopram.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Ca2+ antagonists effect an antidepressant-like adaptation of the NMDA receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Swim Stress Increases the Potency of Glycine at the N-Methyl-d-Aspartate Receptor Complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

On the slowness of action of tricyclic antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Down-regulation of cortical beta-adrenoceptors by chronic treatment with functional NMDA antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Electroconvulsive seizures increase levels of pGlu-Glu-Pro-NH2 (EEP) in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Effects of fluvoxamine on the protein phosphorylation system associated with rat neuronal microtubules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

The effect of prolonged imipramine and electroconvulsive shock treatment on calcium/calmodulin-dependent protein kinase II in the hippocampus of rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Depression by chronic electroconvulsive treatment of clonidine hypotherma and [3H]clonidine binding to rat cortical membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Antidepressant-like properties of prepro-TRH 178-199: acute effects in the forced swim test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Pharmacological actions of the antidepressant venlafaxine beyond aminergic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

The catecholamine hypothesis of affective disorders: a review of supporting evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Cyclic AMP-dependent protein kinase in subtypes of major depression and normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

cAMP-dependent protein kinase activity in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Oligodeoxynucleotides antisense to mRNA encoding protein kinase A, protein kinase C, and beta-adrenergic receptor kinase reveal distinctive cell-type-specific roles in agonist-induced desensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Antidepressants for the new millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

The substance P antagonist L-760,735 inhibits stress-induced NK(1) receptor internalisation in the basolateral amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Activators of protein kinase C act at a postreceptor site to amplify cyclic AMP production in rat pinealocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Mode of action of antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Localization of subspecies of protein kinase C in the mammalian central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Oxytocin as a possible mediator of SSRI-induced antidepressant effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Complex Action of Antidepressant Treatment on Central Adrenergic System: Possible Relevance to Clinical Effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Chronic electroconvulsive treatment enhances the density of [3H]prazosin binding sites in the central nervous system of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Chronic administration of antidepressant drugs increases the density of cortical [3H]prazosin binding sites in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP gererating system in the rat limbic forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Differential effects of electroconvulsive shock on the glutamate receptor mRNAs for NR2A, NR2B and mGluR5b.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

The mesolimbic dopamine system as a target for rapid antidepressant action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

How long should pindolol be associated with paroxetine to improve the antidepressant response?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Deep magnetic brain stimulation--the end of psychiatric electroshock therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Preliminary comparison of behavioral and biochemical effects of chronic transcranial magnetic stimulation and electroconvulsive shock in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

Psychotherapeutic Profile of a New Psychoactive Drug Trazodone (AF-1161)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

inferred from DOI database lookup

7 January 2021

based on heuristic

(Z)-dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl) propene (h 102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900565-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(00)00565-3

1 reference

30 July 2017

1 reference

PubMed ID

11033340